Figure 4 shows the cumulative survival curves for vehicle treated animals, animals treated with inefficacious doses of the CXCR4 agonists and for animals treated with the CXCR4 agonists at doses that prevented ARDS from series 1–3. The gene discussed is CXCR4; the disease is acute respiratory distress syndrome.